Oral IIa and Xa Inhibitors for Prevention of Stroke in Atrial Fibrillation: Clinical Studies and Regulatory Considerations.

http://www.medworm.com/index.php?rid=6315054&cid=c_64_13_f&fid=38034&url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2FPubMed%2F22564122%3Fdopt%3DAbstract

Comments are closed.